{
    "Trade/Device Name(s)": [
        "Element\u2122 plus Blood Glucose Monitoring System",
        "Element\u2122 plus Test Strips",
        "Element\u2122 plus Blood Glucose Meter",
        "Element\u2122 plus Glucose Control Solutions"
    ],
    "Submitter Information": "Infopia Co., Ltd.",
    "510(k) Number": "K103021",
    "Predicate Device Reference 510(k) Number(s)": [
        "K072369"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA",
        "JJX"
    ],
    "Summary Letter Date": "October 4, 2011",
    "Summary Letter Received Date": "October 7, 2011",
    "Submission Date": "September 8, 2011",
    "Regulation Number(s)": [
        "21 CFR 862.1345",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Glucose Test System",
        "Quality control material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Element\u2122 plus Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical detection"
    ],
    "Methodologies": [
        "Quantitative measurement"
    ],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strip",
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for Element\u2122 plus Blood Glucose Monitoring System for quantitative glucose measurement in capillary whole blood using electrochemical detection.",
    "Indications for Use Summary": "Intended for self-testing by people with diabetes at home to quantitatively measure glucose in capillary whole blood from fingertip, ventral palm, dorsal hand, upper arm, forearm, calf, and/or thigh; for single patient use, not for diagnosis or neonatal use.",
    "fda_folder": "Clinical Chemistry"
}